U.S. markets open in 8 hours 31 minutes
  • S&P Futures

    3,998.00
    -21.75 (-0.54%)
     
  • Dow Futures

    31,987.00
    -133.00 (-0.41%)
     
  • Nasdaq Futures

    12,308.00
    -74.75 (-0.60%)
     
  • Russell 2000 Futures

    1,779.20
    -10.30 (-0.58%)
     
  • Crude Oil

    108.42
    -2.07 (-1.87%)
     
  • Gold

    1,806.10
    -2.10 (-0.12%)
     
  • Silver

    20.99
    -0.02 (-0.08%)
     
  • EUR/USD

    1.0401
    -0.0015 (-0.15%)
     
  • 10-Yr Bond

    2.9350
    0.0000 (0.00%)
     
  • Vix

    28.87
    -2.90 (-9.13%)
     
  • GBP/USD

    1.2241
    -0.0021 (-0.18%)
     
  • USD/JPY

    129.0210
    -0.1640 (-0.13%)
     
  • BTC-USD

    30,338.54
    +716.00 (+2.42%)
     
  • CMC Crypto 200

    681.43
    +0.33 (+0.05%)
     
  • FTSE 100

    7,418.15
    +184.81 (+2.55%)
     
  • Nikkei 225

    26,592.13
    +164.48 (+0.62%)
     

Myovant Sciences Ltd. (MYOV) Q3 2021 Earnings Call Transcript

·34 min read
Myovant Sciences Ltd. (MYOV) Q3 2021 Earnings Call Transcript
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

At this time, I'd like to turn the call over to Ryan Crowe, vice president of investor relations at Myovant. Good morning and thanks for joining us today to review the financial results of Myovant's third quarter of fiscal year 2021 and to discuss other corporate and business updates. Joining me for today's call, are David Marek, Myovant's chief executive officer; Uneek Mehra, chief financial and business officer; Lauren Merendino, chief commercial officer; and Dr. Juan Camilo Arjona, chief medical officer.